Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 101–150 of 334 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05617430	Combination Therapy of HAIC, Sintilimab and Bevacizumab for Advanced Hepatocellular Carcinoma	unknown	Phase 2	43	Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER	1	Nov 15, 2022	clinicaltrials
NCT04718909	Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC(REGSIN)	unknown	Phase 2	166	Second Affiliated Hospital of Guangzhou Medical UniversityOTHER